Anupam Rasayan India Limited CC-May26.pdf · 2026-05-25
What could the expected pro forma revenue contribution be post consolidation of all entities and whether there are any long-term plans around the merger or delisting of Bliss GVS Pharma?
Understood. Understood. Got it, sir. Sir, could you also elaborate on the key synergies expected from the Bliss acquisition, the likely time line benefits to reflect in financial? And what could the funding structure of the transaction be? And is it expected to be EPS accretive going forward?